Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 99

1.

Effectiveness of an influenza A (H1N1) 2009 monovalent vaccine among Japanese pregnant women: a prospective observational study assessing antibody efficacy.

Fukushima W, Ohfuji S, Deguchi M, Kawabata K, Hatayama H, Yoshida H, Maeda A, Hirota Y.

Vaccine. 2012 Dec 14;30(52):7630-6. doi: 10.1016/j.vaccine.2012.10.027. Epub 2012 Oct 18.

PMID:
23085364
2.

Maternal immune response and neonatal seroprotection from a single dose of a monovalent nonadjuvanted 2009 influenza A(H1N1) vaccine: a single-group trial.

Tsatsaris V, Capitant C, Schmitz T, Chazallon C, Bulifon S, Riethmuller D, Picone O, Poulain P, Lewin F, Lainé F, Jacqz-Aigrain E, Aboulker JP, Launay O; Inserm C09-33 PREFLUVAC (Immunogenicity and Safety of an Inactivated Nonadjuvanted A[H1N1v] Influenza Vaccine in Pregnant Women) Study Group.

Ann Intern Med. 2011 Dec 6;155(11):733-41. doi: 10.7326/0003-4819-155-11-201112060-00005.

PMID:
22147712
3.

Immunogenicity of a monovalent 2009 influenza A (H1N1) vaccine among pregnant women: lowered antibody response by prior seasonal vaccination.

Ohfuji S, Fukushima W, Deguchi M, Kawabata K, Yoshida H, Hatayama H, Maeda A, Hirota Y.

J Infect Dis. 2011 May 1;203(9):1301-8. doi: 10.1093/infdis/jir026.

4.

Seroprevalence of pandemic H1N1 antibody among health care workers in Hong Kong following receipt of monovalent 2009 H1N1 influenza vaccine.

Zhou Y, Ng DM, Seto WH, Ip DK, Kwok HK, Ma ES, Ng S, Lau LL, Peiris JS, Cowling BJ.

PLoS One. 2011;6(11):e27169. doi: 10.1371/journal.pone.0027169. Epub 2011 Nov 10.

5.

Immunogenicity and safety of a China-made monovalent pandemic (H1N1) 2009 influenza A vaccine in healthcare workers in Guangzhou, China.

Zhan Y, Yang Z, Li L, Ye D, Wu H, Fu R, Zhao S, Wang Y, Zhou R, Chen R.

Jpn J Infect Dis. 2011;64(3):190-4.

6.

Improved serological response to H1N1 monovalent vaccine associated with viral suppression among HIV-1-infected patients during the 2009 influenza (H1N1) pandemic in the Southern Hemisphere.

Maruszak H, Jeganathan S, Smith DE, Robertson P, Barnes T, Furner V.

HIV Med. 2012 Jul;13(6):352-7. doi: 10.1111/j.1468-1293.2011.00987.x. Epub 2012 Feb 2.

7.

Response to a monovalent 2009 influenza A (H1N1) vaccine.

Greenberg ME, Lai MH, Hartel GF, Wichems CH, Gittleson C, Bennet J, Dawson G, Hu W, Leggio C, Washington D, Basser RL.

N Engl J Med. 2009 Dec 17;361(25):2405-13. doi: 10.1056/NEJMoa0907413. Epub 2009 Sep 10.

8.

Poor immune response to a standard single dose non-adjuvanted vaccination against 2009 pandemic H1N1 influenza virus A in the adult and elder hemodialysis patients.

Chang YT, Guo CY, Tsai MS, Cheng YY, Lin MT, Chen CH, Shen D, Wang JR, Sung JM.

Vaccine. 2012 Jul 13;30(33):5009-18. doi: 10.1016/j.vaccine.2012.05.016. Epub 2012 May 30.

PMID:
22658967
9.

Seroprevalence of influenza A H1N1 and seroconversion of mothers and infants induced by a single dose of monovalent vaccine.

Chao A, Huang YC, Chang YL, Wang TH, Chang SD, Wu TS, Wu TL, Chao AS.

Taiwan J Obstet Gynecol. 2013 Sep;52(3):356-9. doi: 10.1016/j.tjog.2013.06.002.

10.

Immunogenicity of an inactivated monovalent 2009 H1N1 influenza vaccine in pregnant women.

Jackson LA, Patel SM, Swamy GK, Frey SE, Creech CB, Munoz FM, Artal R, Keitel WA, Noah DL, Petrie CR, Wolff M, Edwards KM.

J Infect Dis. 2011 Sep 15;204(6):854-63. doi: 10.1093/infdis/jir440.

11.

A randomized clinical trial to identify the optimal antigen and MF59(®) adjuvant dose of a monovalent A/H1N1 pandemic influenza vaccine in healthy adult and elderly subjects.

Hatz C, von Sonnenburg F, Casula D, Lattanzi M, Leroux-Roels G.

Vaccine. 2012 May 14;30(23):3470-7. doi: 10.1016/j.vaccine.2012.03.017. Epub 2012 Mar 22.

PMID:
22446638
12.

Immunogenicity and safety of inactivated monovalent 2009 H1N1 influenza A vaccine in immunocompromised children and young adults.

Hakim H, Allison KJ, Van De Velde LA, Li Y, Flynn PM, McCullers JA.

Vaccine. 2012 Jan 20;30(5):879-85. doi: 10.1016/j.vaccine.2011.11.105. Epub 2011 Dec 9.

PMID:
22155630
13.

Pre-vaccination immunity and immune responses to a cell culture-derived whole-virus H1N1 vaccine are similar to a seasonal influenza vaccine.

Ehrlich HJ, Müller M, Kollaritsch H, Pinl F, Schmitt B, Zeitlinger M, Loew-Baselli A, Kreil TR, Kistner O, Portsmouth D, Fritsch S, Maritsch F, Aichinger G, Pavlova BG, Barrett PN.

Vaccine. 2012 Jun 22;30(30):4543-51. doi: 10.1016/j.vaccine.2012.03.061. Epub 2012 Apr 1.

PMID:
22475864
14.

Immune response to 2009 pandemic H1N1 influenza virus A monovalent vaccine in children with cancer.

Yen TY, Jou ST, Yang YL, Chang HH, Lu MY, Lin DT, Lin KH, Huang LM, Chang LY.

Pediatr Blood Cancer. 2011 Dec 15;57(7):1154-8. doi: 10.1002/pbc.23113. Epub 2011 Mar 21.

PMID:
21425448
15.

Immunogenicity and safety of a novel AS03(A)-adjuvanted H1N1 2009 pandemic influenza vaccine in adults in Japan.

Ikematsu H, Nagai H, Kawashima M, Kawakami Y, Tenjinbaru K, Maeda A, Li P, Gillard P, Roman F.

Hum Vaccin. 2010 Nov;6(11):888-93. Epub 2010 Nov 1.

PMID:
20980795
16.

Safety and immunogenicity of a 2009 influenza A (H1N1) vaccine in hemodialysis patients.

Lertdumrongluk P, Changsirikulchai S, Limkunakul C, Prachukthum P, Punpiput P, Buppanharun R, Chotpitayasunondh C.

Vaccine. 2012 Feb 1;30(6):1108-14. doi: 10.1016/j.vaccine.2011.12.023. Epub 2011 Dec 15.

PMID:
22178515
17.

Reduced immune response to influenza A (H1N1) 2009 monovalent vaccine in HIV-infected Japanese subjects.

Yanagisawa N, Maeda K, Ajisawa A, Imamura A, Suganuma A, Ando M, Takayama N, Okuno Y.

Vaccine. 2011 Aug 5;29(34):5694-8. doi: 10.1016/j.vaccine.2011.06.003. Epub 2011 Jun 29.

PMID:
21689709
18.

Host immune response to A(H1N1)pdm09 vaccination and infection: a one-year prospective study on six cohorts of subjects.

Liu W, Ma MJ, Tang F, He C, Zhang XA, Jiang LF, Xin DS, Hu CY, Looman C, Cao WC.

Vaccine. 2012 Jul 6;30(32):4785-9. doi: 10.1016/j.vaccine.2012.05.030. Epub 2012 May 24.

PMID:
22633868
19.

Effect of two injections of non-adjuvanted influenza A H1N1pdm2009 vaccine in renal transplant recipients: INSERM C09-32 TRANSFLUVAC trial.

Le Corre N, Thibault F, Pouteil Noble C, Meiffrédy V, Daoud S, Cahen R, Charreau I, Bottigioli D, Dollinger C, Aboulker JP, Autran B, Morelon E, Barrou B.

Vaccine. 2012 Dec 14;30(52):7522-8. doi: 10.1016/j.vaccine.2012.10.047. Epub 2012 Oct 25.

PMID:
23103195
20.

Immunogenicity and safety of a monovalent vaccine for the 2009 pandemic influenza virus A (H1N1) in children and adolescents.

Lu CY, Shao PL, Chang LY, Huang YC, Chiu CH, Hsieh YC, Lin TY, Huang LM.

Vaccine. 2010 Aug 16;28(36):5864-70. doi: 10.1016/j.vaccine.2010.06.059. Epub 2010 Jul 13.

PMID:
20600484
Items per page

Supplemental Content

Write to the Help Desk